Literature DB >> 16682640

Transferable anticancer innate immunity in spontaneous regression/complete resistance mice.

Amy M Hicks1, Gregory Riedlinger, Mark C Willingham, Martha A Alexander-Miller, C Von Kap-Herr, Mark J Pettenati, Anne M Sanders, Holly M Weir, Wei Du, Joseph Kim, Andrew J G Simpson, Lloyd J Old, Zheng Cui.   

Abstract

Spontaneous regression/complete resistance (SR/CR) mice resist very high doses of cancer cells that are lethal to WT mice even at low doses. In this study, we show that this resistance is mediated by rapid infiltration of leukocytes, mostly of innate immunity, in both primary and repeated challenges. Formation of rosettes with infiltrating natural killer cells, neutrophils, and macrophages was required for the subsequent destruction of cancer cells through rapid cytolysis. Highly purified natural killer cells, macrophages, and neutrophils from the SR/CR mice independently killed cancer cells in vitro. The independent killing activity by each subset of effector cells is consistent with the observation that the resistance was abolished by depleting total infiltrating leukocytes but not by depleting only one or two subsets of leukocytes. The resistance was completely transferable to WT recipient mice through SR/CR splenocytes, bone marrow cells, or enriched peritoneal macrophages, either for prevention against subsequent cancer challenges or eradication of established malignancy at distant sites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682640      PMCID: PMC1458507          DOI: 10.1073/pnas.0602382103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Possible role of immune surveillance at the initial phase of metastasis produced by B16BL6 melanoma cells.

Authors:  H Kikkawa; H Imafuku; H Tsukada; N Oku
Journal:  FEBS Lett       Date:  2000-02-11       Impact factor: 4.124

Review 2.  The winding road to the discovery of the SR/CR mice.

Authors:  Zheng Cui
Journal:  Cancer Immun       Date:  2003-10-16

Review 3.  Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantation.

Authors:  Franco Locatelli; Patrizia Comoli; Daniela Montagna; Francesca Rossi; Liane Daudt; Rita Maccario
Journal:  Best Pract Res Clin Haematol       Date:  2004-09       Impact factor: 3.020

4.  Influence of genotype of host on regression of solid and ascitic forms of sarcoma 180 and effect of chemotherapy on the solid form.

Authors:  G S Tarnowski; I M Mountain; C C Stock
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

5.  Effect of thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages.

Authors:  P C Leijh; T L van Zwet; M N ter Kuile; R van Furth
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

Review 6.  Adjuvant immunotherapy for solid tumors: from promise to clinical application.

Authors:  Simone Mocellin; Carlo R Rossi; Mario Lise; Francesco M Marincola
Journal:  Cancer Immunol Immunother       Date:  2002-09-17       Impact factor: 6.968

Review 7.  Generation of tumor-specific T-cell therapies.

Authors:  Emma Morris; Dan Hart; Liquan Gao; Aristotle Tsallios; Shao-An Xue; Hans Stauss
Journal:  Blood Rev       Date:  2005-06-22       Impact factor: 8.250

8.  The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.

Authors:  G C Koo; F J Dumont; M Tutt; J Hackett; V Kumar
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

9.  Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice.

Authors:  Zheng Cui; Mark C Willingham; Amy M Hicks; Martha A Alexander-Miller; Timothy D Howard; Gregory A Hawkins; Mark S Miller; Holly M Weir; Wei Du; Cynthia J DeLong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

10.  Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.

Authors:  S Singh; S R Ross; M Acena; D A Rowley; H Schreiber
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  59 in total

1.  Strain-specific susceptibility for pulmonary metastasis of sarcoma 180 cells in inbred mice.

Authors:  Haris G Vikis; Erin N Jackson; Alexander S Krupnick; Andrew Franklin; Andrew E Gelman; Qiong Chen; David Piwnica-Worms; Ming You
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5-fluorouracil chemotherapy in the B16 melanoma model.

Authors:  Xiaoyi Qu; Mildred A R Felder; Zulmarie Perez Horta; Paul M Sondel; Alexander L Rakhmilevich
Journal:  Int Immunopharmacol       Date:  2013-11-04       Impact factor: 4.932

3.  Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice.

Authors:  John R Stehle; Michael J Blanks; Gregory Riedlinger; Jung W Kim-Shapiro; Anne M Sanders; Jonathan M Adams; Mark C Willingham; Zheng Cui
Journal:  BMC Cancer       Date:  2009-09-15       Impact factor: 4.430

4.  Tumor entrained neutrophils inhibit seeding in the premetastatic lung.

Authors:  Zvi Granot; Erik Henke; Elizabeth A Comen; Tari A King; Larry Norton; Robert Benezra
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

5.  Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression.

Authors:  M Jaganjac; M Poljak-Blazi; R J Schaur; K Zarkovic; S Borovic; A Cipak; M Cindric; K Uchida; G Waeg; N Zarkovic
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

6.  Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements.

Authors:  Anne M Sanders; John R Stehle; Michael J Blanks; Gregory Riedlinger; Jung W Kim-Shapiro; Arta M Monjazeb; Jonathan M Adams; Mark C Willingham; Zheng Cui
Journal:  BMC Cancer       Date:  2010-03-31       Impact factor: 4.430

7.  The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction.

Authors:  Gregory Riedlinger; Jonathan Adams; John R Stehle; Michael J Blanks; Anne M Sanders; Amy M Hicks; Mark C Willingham; Zheng Cui
Journal:  BMC Cancer       Date:  2010-05-03       Impact factor: 4.430

8.  Influenza a virus induces an immediate cytotoxic activity in all major subsets of peripheral blood mononuclear cells.

Authors:  Sanda Sturlan; Monika Sachet; Suzann Baumann; Irina Kuznetsova; Andreas Spittler; Michael Bergmann
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

9.  Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.

Authors:  Andrea Worschech; Nanhai Chen; Yong A Yu; Qian Zhang; Zoltan Pos; Stephanie Weibel; Viktoria Raab; Marianna Sabatino; Alessandro Monaco; Hui Liu; Vladia Monsurró; R Mark Buller; David F Stroncek; Ena Wang; Aladar A Szalay; Francesco M Marincola
Journal:  BMC Genomics       Date:  2009-07-07       Impact factor: 3.969

10.  Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment.

Authors:  Antonio Brú; Juan-Carlos Souto; Sonia Alcolea; Rosa Antón; Angel Remacha; Mercedes Camacho; Marta Soler; Isabel Brú; Amelia Porres; Luis Vila
Journal:  Mediators Inflamm       Date:  2010-02-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.